Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.

@article{Grimm2012ComparativeAO,
  title={Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.},
  author={P. D. Grimm and Ignace Billiet and David Bostwick and Adam P Dicker and Steven R. Frank and Jos J Immerzeel and Mira Keyes and Patrick Kupelian and William Robert Lee and Stefan A. Machtens and Jyoti S. Mayadev and Brian Joseph Moran and Gregory S. Merrick and Jeremy Millar and Mack Iii Roach and Richard Douglas Stock and Katsuto Shinohara and Mark H. Scholz and Ernst Albrecht Weber and Anthony L. Zietman and Michael Zelefsky and Jason K.F. Wong and Stacy Wentworth and Robyn Vera and Stephen E M Langley},
  journal={BJU international},
  year={2012},
  volume={109 Suppl 1},
  pages={
          22-9
        }
}
What's known on the subject? and What does the study add? Very few comparative studies to date evaluate the results of treatment options for prostate cancer using the most sensitive measurement tools. PSA has been identified as the most sensitive tool for measuring treatment effectiveness. To date, comprehensive unbiased reviews of all the current literature are limited for prostate cancer. This is the first large scale comprehensive review of the literature comparing risk stratified patients… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 166 CITATIONS, ESTIMATED 44% COVERAGE

Salvage cryosurgery for locally recurrent prostate cancer after primary cryotherapy

  • International Urology and Nephrology
  • 2014
VIEW 12 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Patterns of failure after iodine-125 seed implantation for prostate cancer.

  • Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 2014
VIEW 5 EXCERPTS
CITES RESULTS
HIGHLY INFLUENCED

Prostate-specific antigen bounce after high-dose-rate monotherapy for prostate cancer.

  • International journal of radiation oncology, biology, physics
  • 2013
VIEW 9 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Low dose rate prostate brachytherapy

  • Translational andrology and urology
  • 2018
VIEW 17 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2012
2019

CITATION STATISTICS

  • 11 Highly Influenced Citations

  • Averaged 17 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 65 REFERENCES

Long - term survival after radical prostatectomy for men with high Gleason sum in pathologic specimens

KA Roehl, M Han, CG Ramos, JA Antenor, WJ Catalona
  • Urology
  • 2010

Long term outcomes for patients with prostate cancer having intermediate and high risk disease , treated with combination external radiation and brachytherapy

AY Ho, RJ Burri, JA Cesaretti, NN Stone, RG Stock
  • J Oncol
  • 2010

Similar Papers

Loading similar papers…